Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 40.27B | 40.26B | 44.12B | 43.47B | 42.52B | 42.27B |
Gross Profit | 10.51B | 15.96B | 16.68B | 16.76B | 15.56B | 16.98B |
EBITDA | 11.75B | 12.96B | 13.12B | 12.98B | 11.64B | 12.89B |
Net Income | 1.13B | 2.35B | 2.44B | 2.15B | 233.00M | 4.82B |
Balance Sheet | ||||||
Total Assets | 101.62B | 103.87B | 110.05B | 113.17B | 111.32B | 110.92B |
Cash, Cash Equivalents and Short-Term Investments | 10.58B | 12.21B | 8.32B | 10.50B | 10.89B | 11.35B |
Total Debt | 7.51B | 42.67B | 8.57B | 53.11B | 52.07B | 51.56B |
Total Liabilities | 69.00B | 68.71B | 74.95B | 83.17B | 81.46B | 79.52B |
Stockholders Equity | 29.42B | 31.77B | 31.82B | 26.83B | 26.84B | 28.75B |
Cash Flow | ||||||
Free Cash Flow | 3.15B | 3.48B | 4.22B | 2.46B | 2.49B | 4.15B |
Operating Cash Flow | 10.19B | 10.20B | 12.05B | 11.23B | 11.24B | 12.70B |
Investing Cash Flow | -4.86B | -1.46B | -7.01B | -10.45B | -5.97B | -5.56B |
Financing Cash Flow | -5.94B | -5.73B | -5.46B | -3.34B | -4.84B | -5.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | €38.39B | 34.02 | 4.23% | 5.18% | -5.05% | -49.01% | |
72 Outperform | €4.34B | 8.92 | 11.73% | 5.79% | 9.08% | -22.55% | |
71 Outperform | €1.81B | 9.62 | 9.58% | 6.98% | -0.32% | 0.64% | |
66 Neutral | €3.14B | 8.30 | 2.26% | 1.26% | ― | ― | |
65 Neutral | €4.07B | 17.11 | -2.44% | 3.86% | 1.88% | -16.39% | |
64 Neutral | €19.30B | 11.30 | 17.51% | 4.68% | 9.88% | 16.84% | |
63 Neutral | €2.48B | 244.29 | -2.14% | 8.30% | -0.99% | 93.75% |